Annual Total Liabilities
$18.86 M
-$2.83 M-13.04%
December 31, 2023
Summary
- As of February 7, 2025, INMB annual total liabilities is $18.86 million, with the most recent change of -$2.83 million (-13.04%) on December 31, 2023.
- During the last 3 years, INMB annual total liabilities has risen by +$16.96 million (+891.69%).
- INMB annual total liabilities is now -13.04% below its all-time high of $21.69 million, reached on December 31, 2022.
Performance
INMB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$14.11 M
-$1.27 M-8.24%
September 30, 2024
Summary
- As of February 7, 2025, INMB quarterly total liabilities is $14.11 million, with the most recent change of -$1.27 million (-8.24%) on September 30, 2024.
- Over the past year, INMB quarterly total liabilities has dropped by -$1.27 million (-8.24%).
- INMB quarterly total liabilities is now -34.96% below its all-time high of $21.69 million, reached on December 31, 2022.
Performance
INMB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
INMB Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -13.0% | -8.2% |
3 y3 years | +891.7% | -8.2% |
5 y5 years | +2189.6% | -8.2% |
INMB Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -13.0% | at low | -35.0% | at low |
5 y | 5-year | -13.0% | +2092.0% | -35.0% | +1539.4% |
alltime | all time | -13.0% | +5990.4% | -35.0% | +6573.1% |
INmune Bio Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $14.11 M(-8.2%) |
Jun 2024 | - | $15.37 M(-13.7%) |
Mar 2024 | - | $17.81 M(-5.6%) |
Dec 2023 | $18.86 M(-13.0%) | $18.86 M(+5.0%) |
Sep 2023 | - | $17.97 M(-5.8%) |
Jun 2023 | - | $19.07 M(+2.0%) |
Mar 2023 | - | $18.68 M(-13.9%) |
Dec 2022 | $21.69 M(+10.0%) | $21.69 M(+7.9%) |
Sep 2022 | - | $20.09 M(+12.4%) |
Jun 2022 | - | $17.88 M(-4.5%) |
Mar 2022 | - | $18.71 M(-5.1%) |
Dec 2021 | $19.72 M | $19.72 M(+1.6%) |
Sep 2021 | - | $19.42 M(+11.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2021 | - | $17.47 M(+655.5%) |
Mar 2021 | - | $2.31 M(+21.6%) |
Dec 2020 | $1.90 M(+121.0%) | $1.90 M(+18.1%) |
Sep 2020 | - | $1.61 M(+18.2%) |
Jun 2020 | - | $1.36 M(+7.2%) |
Mar 2020 | - | $1.27 M(+47.7%) |
Dec 2019 | $860.50 K(+4.5%) | $860.50 K(+25.3%) |
Sep 2019 | - | $687.00 K(-0.8%) |
Jun 2019 | - | $692.70 K(-11.3%) |
Mar 2019 | - | $780.90 K(-5.2%) |
Dec 2018 | $823.80 K(+166.0%) | $823.80 K(+289.7%) |
Sep 2018 | - | $211.40 K(-31.7%) |
Dec 2017 | $309.70 K(-48.5%) | $309.70 K |
Dec 2016 | $600.80 K | - |
FAQ
- What is INmune Bio annual total liabilities?
- What is the all time high annual total liabilities for INmune Bio?
- What is INmune Bio annual total liabilities year-on-year change?
- What is INmune Bio quarterly total liabilities?
- What is the all time high quarterly total liabilities for INmune Bio?
- What is INmune Bio quarterly total liabilities year-on-year change?
What is INmune Bio annual total liabilities?
The current annual total liabilities of INMB is $18.86 M
What is the all time high annual total liabilities for INmune Bio?
INmune Bio all-time high annual total liabilities is $21.69 M
What is INmune Bio annual total liabilities year-on-year change?
Over the past year, INMB annual total liabilities has changed by -$2.83 M (-13.04%)
What is INmune Bio quarterly total liabilities?
The current quarterly total liabilities of INMB is $14.11 M
What is the all time high quarterly total liabilities for INmune Bio?
INmune Bio all-time high quarterly total liabilities is $21.69 M
What is INmune Bio quarterly total liabilities year-on-year change?
Over the past year, INMB quarterly total liabilities has changed by -$1.27 M (-8.24%)